Mayo Clinic tests novel vaccine for aggressive brain tumors

A **vaccine** that has significantly increased life expectancy in early tests of patients with glioblastoma multiforme (GBM) − the most common, most aggressive form of **brain cancer** in adults − is now being offered through a clinical trial at **Mayo Clinic** in Jacksonville. The vaccine represents a fresh and fairly simple approach to treating this cancer, says neurosurgeon Kent New, M.D., Ph.D., who will be leading the study at Mayo. About 40% of these tumors display a particular **protein** on their surface and the vaccine is designed to trick the patient’s **immune system** into thinking the protein is “foreign” in order to mount a killing response. Whole article: "physorg":[ http://physorg.com/news112280502.html] Source: "Mayo Clinic":[ http://www.mayoclinic.com/]

---